Dicot AB (XSAT:DICOT) Other Current Receivables : kr0.00 Mil (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Dicot AB Other Current Receivables?

Dicot AB's Other Current Receivables for the quarter that ended in Mar. 2024 was kr0.00 Mil.

Dicot AB's annual Other Current Receivables increased from Dec. 2021 (kr1.42 Mil) to Dec. 2022 (kr1.49 Mil) and increased from Dec. 2022 (kr1.49 Mil) to Dec. 2023 (kr2.80 Mil).

Dicot AB Other Current Receivables Historical Data

The historical data trend for Dicot AB's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dicot AB Other Current Receivables Chart

Dicot AB Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Current Receivables

Get a 7-Day Free Trial

1.35

1.25

1.42

1.49

2.80

Dicot AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Current Receivables	Get a 7-Day Free Trial															-	-	-	2.80	-

Dicot AB Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

Dicot AB Other Current Receivables Related Terms

Thank you for viewing the detailed overview of Dicot AB's Other Current Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Dicot AB (XSAT:DICOT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dicot AB (XSAT:DICOT) » Definitions » Other Current Receivables

Comparable Companies

Traded in Other Exchanges

KN0:Germany

Address

Dag Hammarskjolds vag 30, Uppsala, SWE, SE 752 37

Website

http://www.dicot.se

Dicot AB is engaged in developing drugs against sexual dysfunction in Sweden. Its important products are Libiguin which is used for the treatment of erectile dysfunction and premature ejaculation in men, as well as potentially also for the treatment of decreased lust.

Dicot AB (XSAT:DICOT) Headlines

No Headlines